Evidence map›Paper›PMID 35547391›Full record

ArticleFrontiers in molecular biosciences2022

The Value of H2BC12 for Predicting Poor Survival Outcomes in Patients With WHO Grade II and III Gliomas.

Jie Zhou, Zhaoquan Xing, Yilei Xiao, Mengyou Li, Xin Li, Ding Wang, Zhaogang Dong

Open access · goldAbstract read
In one paragraph

Article in Frontiers in molecular biosciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Jie ZhouDepartment of Nursing, Liaocheng Vocational and Technical College, Liaocheng, China.
Zhaoquan XingDepartment of Urology, Qilu Hospital of Shandong University, Jinan, China.
Yilei XiaoDepartment of Neurosurgery, Liaocheng People's Hospital, Liaocheng, China.
Mengyou LiDepartment of Neurosurgery, Liaocheng People's Hospital, Liaocheng, China.
Xin LiDepartment of Neurosurgery, Liaocheng People's Hospital, Liaocheng, China.
Ding WangDepartment of Clinical Laboratory, Qilu Hospital of Shandong University, Jinan, China.
Zhaogang DongDepartment of Clinical Laboratory, Qilu Hospital of Shandong University, Jinan, China.
Liaocheng People's Hospital · CNQilu Hospital of Shandong University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

diagnosisgliomasH2BC12prognosisTCGA

Identifiers

PMID35547391
PMCPMC9081347
OpenAlexW4224323289

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.